The company announced that its revenue increased to $ 259 million and that the increase was due to the acceleration of the company’s long-term growth strategy combined with the one-time impact of customer site closures. during the comparative period related to the COVID-19 pandemic.
Net sales for the full year 2021 increased 26% to $ 931 million, the company also said.
The Protein Science segment, through which the company supplies specialized proteins such as cytokines and growth factors, immunoassays, antibodies and reagents, reported net sales of 192.3 million in the fourth quarter of 2021, an increase of 51% from the $ 127.3 million in the fourth quarter of the fiscal year. 2020.
Bio-Techne also reported fourth quarter Fiscal 2021 net sales of $ 67.1 million in its Diagnostics and Genomics business, an increase of 38% from $ 48.7 million for the fourth quarter of fiscal 2020. This segment provides blood chemistry and blood gas quality controls, controls, immunoassays, in situ hybridization products and exosome-based diagnostic products.
Copyright © 2021 scienceboard.net